...
首页> 外文期刊>Journal of Endocrinology and Metabolism >Demographic and Clinical Factors Associated With the Appropriate Target Thyroid-Stimulating Hormone Values in Patients With Primary Hypothyroidism Treated With Levothyroxine
【24h】

Demographic and Clinical Factors Associated With the Appropriate Target Thyroid-Stimulating Hormone Values in Patients With Primary Hypothyroidism Treated With Levothyroxine

机译:左甲状腺素治疗原发性甲状腺功能减退症患者中与适当的目标甲状腺刺激激素值相关的人口统计学和临床​​因素

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Hypothyroidism control is inadequate in up to 30-40% of patients. This study aimed to determine the control rate of primary hypothyroidism and the demographic and clinical factors associated with the hypothyroidism control.Methods: An observational and retrospective study was conducted between January 2014 and October 2015. Data were obtained from 174 medical records. Regarding hypothyroidism control analysis, patients were subdivided into two groups: the appropriate control group and the inappropriate control group. Autoimmune and post-surgical hypothyroidism secondary to benign nodular thyroid disease (BNTD) was classified as of benign etiology, and differentiated thyroid carcinoma (DTC) as of malignant origin.Results: The majority of patients consisted of women (93.68%), with a mean age of 55.53 ± 14.13 years old. The most common etiology was of autoimmune origin (41.95%). Adequate control of hypothyroidism was found in 55.17% of patients. Patients who had longer disease duration (P = 0.002), who kept using the same brand of levothyroxine (P = 0.001) and who were non-smokers (P = 0.004) had better control, and hypothyroidism from benign etiology also tended to be associated with better control (P = 0.08).Conclusions: Primary hypothyroidism still has a high percentage of poor control seen worldwide, despite its relatively simple treatment. In this study, almost 50% of the patients had inadequate control of hypothyroidism. The factors associated with good control, both of benign and malignant origin, were related to the use of the same brand of levothyroxine and to not smoking, and the benign etiology group tended to correlate with better treatment control.J Endocrinol Metab. 2016;6(4):109-115doi: http://dx.doi.org/10.14740/jem367w
机译:背景:甲状腺功能减退症的控制在多达30-40%的患者中是不充分的。这项研究旨在确定原发性甲状腺功能减退的控制率以及与甲状腺功能减退相关的人口统计学和临床​​因素。方法:2014年1月至2015年10月进行了一项观察性和回顾性研究。数据来自174份医疗记录。关于甲状腺功能减退症的对照分析,将患者分为两组:适当对照组和不适当对照组。继发于良性结节性甲状腺疾病(BNTD)的自身免疫和术后甲状腺功能减退被归类为良性病因,而恶性起源则为分化型甲状腺癌(DTC)。结果:大多数患者为女性(93.68%),其中平均年龄为55.53±14.13岁。最常见的病因是自身免疫起源的(41.95%)。在55.17%的患者中,甲状腺功能减退得到了充分的控制。疾病持续时间较长(P = 0.002),一直使用相同品牌的左甲状腺素(P = 0.001)和非吸烟者(P = 0.004)的患者具有更好的控制能力,并且良性病因引起的甲状腺功能减退也往往与患者相关结论:尽管治疗相对简单,但原发性甲状腺功能减退症在全球范围内仍具有较高的不良控制率。在这项研究中,几乎50%的患者甲状腺功能减退控制不充分。良性和恶性起源的良好控制相关因素均与使用相同品牌的左甲状腺素有关,并且与不吸烟有关,并且良性病因学组倾向于与更好的治疗控制相关。JEndocrinol Metab。 2016; 6(4):109-115doi:http://dx.doi.org/10.14740/jem367w

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号